Pharmacologic inhibition of mTOR improves lapatinib sensitivity in HER2-overexpressing breast cancer cells with primary trastuzumab resistance (Q35783451)
Jump to navigation
Jump to search
scientific article published on February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacologic inhibition of mTOR improves lapatinib sensitivity in HER2-overexpressing breast cancer cells with primary trastuzumab resistance |
scientific article published on February 2012 |
Statements
1 reference
Pharmacologic inhibition of mTOR improves lapatinib sensitivity in HER2-overexpressing breast cancer cells with primary trastuzumab resistance (English)
1 reference
Sylvia S Gayle
1 reference
Samuel L M Arnold
1 reference
Ruth M O'Regan
1 reference
Rita Nahta
1 reference
1 February 2012
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference